Results 211 to 220 of about 313,604 (267)
Some of the next articles are maybe not open access.

2021 Corticosteroids

2023
Glucocorticosteroids have an over 60-year history in the treatment of inflammatory bowel disease. The major anti-inflammatory effects of glucocorticoids result from interactions between the activated glucocorticoid receptor and transcription factors that mediate the expression of inflammatory genes.
Samson, Charles M., Escher, Johanna C.
openaire   +1 more source

Corticosteroid osteoporosis

Zeitschrift für Rheumatologie, 2000
Corticosteroids are widely used in the treatment of patients with chronic inflammatory diseases. Since the most rapid bone loss occurs in the first 12-24 months after commencing high dose corticosteroids, it is important to consider two different therapeutic situations, (a) prevention in patients starting corticosteroids and (b) treatment of patients ...
openaire   +2 more sources

ANALYSIS OF CORTICOSTEROIDS

Acta Endocrinologica, 1970
ABSTRACT Human transcortin or a high affinity, low capacity corticosteroid-binding protein from the plasma of various species has been used for corticosteroid analysis. The relative specificity varies with the species so that selection of the appropriate plasma source is advantageous.
W R, Slaunwhite, A A, Sandberg
openaire   +2 more sources

Corticosteroids and Growth

New England Journal of Medicine, 1976
One the most conspicuous effects of the glucocorticoid hormones is an inhibition of somatic growth in immature animals.
openaire   +2 more sources

Corticosteroid osteoporosis

Baillière's Clinical Rheumatology, 1993
Glucocorticoids produce osteoporosis via a number of mechanisms, the most important of which is probably inhibition of bone formation. This results in reduction in bone mass of 10-20% at commonly assessed sites, but the bone loss is 30-40% when predominantly trabecular bone is measured.
I R, Reid, A B, Grey
openaire   +2 more sources

Corticosteroids and cognition

Journal of Psychiatric Research, 2001
The brain is a major target organ for corticosteroids. It has been observed that excessive circulatory levels of endogenous and exogenous corticosteroids are frequently associated with cognitive impairment in a wide variety of clinical disease states. Cognition and low levels of corticosteroids have been less well studied.
J K, Belanoff   +3 more
openaire   +2 more sources

Corticosteroid and tuberculosis

British Journal of Tuberculosis and Diseases of the Chest, 1957
Summary It is suggested that, in tuberculosis, the use of corticosteroid with tuberculostatic therapy has no other purpose than (i) to suppress the state of hypersensitivity to the bacillus or its products. (ii) to suppress hypersensitivity of the patient to the tuberculostatic drugs.
openaire   +2 more sources

Corticosteroids and growth

The Journal of Pediatrics, 1988
Les corticosteroides favorisent le catabolisme et peuvent donc gener la croissance. Par contre utilises judicieusement, ils peuvent la permettre en traitant une affection qui entrave la croissance. Revue de quelques elements eclairant sur ces rapports confus: constatations cliniques, rapports avec les mediateurs hormonaux de la croissance et le ...
J S, Hyams, D E, Carey
openaire   +2 more sources

Intralesional corticosteroids

Journal of the American Academy of Dermatology, 1981
Intralesional corticosteroids are commonly used in clinical dermatology. They are an adjunct to topicals and a possible substitution for systemic corticosteroids. Intralesional corticosteroids can be injected via a syringe and needle or with a Dermo-Jet.
openaire   +2 more sources

TREATMENT WITH CORTICOSTEROIDS

Clinics in Chest Medicine, 1997
Oral corticosteroids remain the cornerstone therapy for sarcoidosis. Critical clinical decisions include selecting the patient who should be treated, dose and duration of therapy, and accurate analysis of the anticipated benefits and potential side effects for the individual patient.
R H, Winterbauer   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy